Samantha Ramachandra

Samantha Ramachandra

Auto-generated profile, based on publicly available information

Samantha Ramachandra

District General Hospital, Embilipitiya, Sri Lanka

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2021 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Open access
NPNadisha Sewwandi Piyarathne
Nadisha Sewwandi Piyarathne
RRR.M.S.G.K Rasnayake
R.M.S.G.K Rasnayake
RARandilini Angammana
Randilini Angammana
PCPushpika Chandrasekera
Pushpika Chandrasekera
SRSamantha Ramachandra
Samantha Ramachandra
EGEkta Gupta
Ekta Gupta
Introduction: Oral squamous cell carcinoma (OSCC) and oral potentially malignant disorders (OPMD) are a significant health burden globally. Smoking, alcohol and betel quid are the main risk factors. Lack of screening methods has been highlighted as a significant challenge in management. Salivary biomarkers are proposed as non-invasive diagnostic tools. The aim of this systematic review was to study salivary biomarkers reported in OSCC and OPMD. Specific objectives were to select a salivary biomarker panel suitable for early detection of OSCC and OPMD and to assess relationships between salivary biomarkers and risk factors. Methods: A literature search was conducted in academic databases (Scopus, Medline, Embase and Web of Science) without any restrictions. Following calibration, two blinded reviewers screened the studies and extracted data. A risk of bias assessment was conducted using Newcastle Ottawa scale. 295 studies were included with descriptive data analysis. Expert opinion: A salivary biomarker panel including Interleukin 1β, IL6 and IL8 was selected for OSCC and OPMD. Reported relationships between salivary biomarkers and risk factors are discussed and research gaps are highlighted. Future research should be directed to assess potential salivary biomarkers and their relationships to risk factors in order to understand the biomarker’s role in disease initiation.

1 December 2020 in Stroke
Verified
Journal Article
Closed access
PDF file
PLPeter Langhorne
Peter Langhorne
SRSamantha Ramachandra
Samantha Ramachandra
SCStroke Unit Trialists’ Collaboration
Stroke Unit Trialists’ Collaboration